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ABSTRACT: An efficient stereocontrolled preparation of chiral phenantroindolizidines 
is detailed. The synthesis relies on the stereoselective indium-mediated allylation of 2-
(phenanthren-9-yl)acetaldehyde derivatives with chiral tert-butylsulfinamide. 
Chemoselective transformations from the corresponding homoallylic sulfinamine allow 
the synthesis of the phenantroindolizidines in only three synthetic operations, without 
any detectable racemization. Following this procedure, the synthesis of natural (−)-
tylophorine was successfully accomplished. 
 
Introduction 
The use of plants of the Asclepiadaceae family, including Tylophora indica, 
Cryptocarya and Ficus species, in the traditional medicine led to the discovery of 
phenantroindolizidine alkaloids.1 It has been shown that compounds of this family, from 
which (−)-Antofine, (−)-Tylophorine and (−)-Tylocrebine are representative members 
(Figure 1), display a wide range of biological activities, such as antibacterial,2 
antiasthmatic,3 antiviral4 and anti-inflamamatory5 activities. Moreover, their extremely 
high cytotoxicity (IC50 ~10 nM) against different cancer cell lines by a unique mode of 
action has especially attracted the attention of medicinal chemists.6  
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Figure 1. Naturally occurring phenantroindolizidines. 
Due to the CNS toxicity of natural phenantroindolizidines,7 the search of potent non-
toxic analogues with improved pharmacokinetic properties is a very active research 
area. Interestingly, the unnatural (S)-tylophorine was found to be even more potent in 
the inhibition of some specific cancer cell growth.8 In this context, the development of 
robust methods that allows the rapid construction of the required enantioenriched 
phenantroindolizidine scaffold is a need that has been addressed by a number of 
research groups. Some successful approaches reported in the last decade include the use 
of catalytic methods,9 chiral building blocks10 and chiral auxiliaries.11 Importantly, 
access to both enantiomers, either R- or S-, phenantroindolizidine alkaloids is highly 
desirable to explore their biological profiles and we anticipated that the corresponding 
chiral homoallylc sulfinamines should provide a very convenient entry.12 Herein, we 
report the realization of this strategy.13 
 
Results and discussion 
In our retrosynthetic analysis of phenantroindolizidines we propose the formation of 
ring D in a late stage by a reliable Pictet-Spengler annulation.9a-9c Importantly, the chiral 
tert-butyl sulfinyl auxiliary14 could be removed under the required acidic conditions for 
the cyclization, minimizing functional groups manipulation (Scheme 1). The formation 
of the pyrrolidine intermediate 7 was anticipated by straightforward synthetic 
elaboration of homoallyl sulfinamine 5, which could be prepared from aldehyde 4 using 
a one-pot protocol developed in our group.15 
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Scheme 1. Retrosynthetic Analysis of Phenantroindolizidine. 
 
As outlined in Scheme 2, our synthesis began with the preparation of aldehyde 4. 
Stille coupling of commercially available 9-bromophenanthrene with allyltri-n-butyltin 
afforded compound 2 in excellent yield. After having explored different conditions for 
the oxidative cleavage of the olefinic double bond, including ozonolysis and Johnson-
Lemieux oxidation, aldehyde 4 was efficiently prepared in a two-step procedure. The 
very low solubility of the intermediate diol 3 allowed its purification by recrystallization 
from ethyl acetate, before being oxidatively cleaved by NaIO4. This method afforded 
aldehyde 4 which was pure enough to be used directly in the next step. The indium-
mediated aminoallylation took place with good yield and high diastereoselectivity,16 
either with (SS)-tert-butylsulfinamide to obtain compound 5 or with (RS)-tert-
butylsulfinamide to prepare ent-5.17 
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Scheme 2. Synthesis of Homoallylsulfinamines 5 and ent-5. 
 
Crucial to our synthetic plan was the use chemoselective reactions to prepare 
pyrrolidine 7, while keeping the tert-butylsulfinyl as protecting group. We thus 
submitted intermediate 5 to a hydroboration-oxidation sequence, which took place 
without any detectable oxidation of the sulfur atom, and the obtained sulfinamine-
alcohol 6 was cyclized under Mitsunobu conditions to furnish the desired compound 7 
in very good overall yield.18 Finally, a solution of this compound in TFA was treated 
with aqueous formalin at 90 ºC for 12 h, and deprotection of the amino group was 
followed by the corresponding iminium formation and Pictet-Spengler annulations, 
affording compound 8 in excellent isolated yield. Physical and spectral data of 
compound 8 were in good agreement with those previously reported for a racemic 
sample.19 Following the same route (Scheme 3), but from ent-5 we also prepared 
compound ent-8. Chiral HPLC analysis of both final products clearly evidenced that 
racemization did not occur in the reaction sequence used from each chiral homoallylic 
sulfinamine (5 or ent-5), obtaining identical enantiomeric ratios in the final products 
(95:5 er). Despite the high occurrence of the phenantroindolizidine scaffold in 
prominent bioactive natural products, to our best knowledge this is the first report on the 
synthesis of the enantioenriched parent compounds. 
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Scheme 3. Synthesis of Phenantroindolizidines 7 and ent-7. 
 
Having developed a convenient procedure for the synthesis of phenantroindolizidines, 
the stage was set to target naturally occurring family members and we illustrate the 
applicability of this protocol in the synthesis of (−)-Tylophorine (Scheme 4). The 
synthesis commenced by a two-step homologation of the readily available phenanthryl 
aldehyde 9.20 A Wittig olefination with methoxymethyl phosphorous ylide allowed the 
preparation of a diastereomeric mixture of enol ethers 10 (E/Z 3:2, according to 1H-
NMR), which were hydrolyzed to furnish the required aldehyde 11 in very good overall 
yield. The indium-mediated amino allylation of this aldehyde took place with 75% yield 
to afford homoallylic amine 12 with good diastereoselectivity [95:5 dr, determined by 
1H-NMR and HPLC, see the ESI].16 The hydroboration-oxidation sequence occurred 
with similar good efficiency to the one observed in the preparation of compound 6 and 
the obtained compound 13 was submitted to Mitsunobu cyclization conditions, which 
also took place with 73% isolated yield. Although the pyrrolidine 14 could not be 
efficiently separated from the triphenylphosphine oxide byproduct, it was used in the 
next step. Deprotection of the amino group with HCl was followed by in-situ addition of 
aqueous formalin and after heating to 90 ºC for 12 h, the desired (R)-(−)-tylophorine 
was obtained, which was isolated in good yield after chromatography purification. The 
spectroscopic data and the specific optical rotation value {[α]D20 -85.0 (c 0.5, CHCl3)} 
obtained for our synthetic tylophorine are in accordance with those reported for the 
natural compound.9b, 10b, 11 
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Scheme 4. Synthesis of (−)-Tylophorine. 
 
Conclusions 
We have developed a practical procedure to build enantioenriched 
phenantroindolizidines in which the indium-mediated aminoallylation of 2-
(phenanthren-9-yl)acetaldehyde derivatives with chiral tert-butylsulfinamide is a key 
step. Importantly, in this synthetic approach the tert-butylsulfinyl group acted not only 
as a chiral director group, but also as a protecting group in the whole sequence, allowing 
the formation of target phenantroindolizidines in only three synthetic operations from 
the corresponding homoallylic amine. From each enantiomer of tert-butylsulfinamide, 
the corresponding enantioenriched parent phenantroindolizidine was prepared, the 
enantiomeric ratio of the final products being identical to the diastereomeric ratio of the 
corresponding chiral homoallylic sulfinamines. The usefulness of this protocol was 
illustrated by the synthesis of natural (−)-tylophorine and we hope it will find 
applications in the optimization of the biological profile of this family of bioactive 
compounds. 
 
Experimental 
General Remarks. TLC were performed on silica gel 60 F254, using aluminum plates 
and visualized by exposure to ultraviolet light or with phosphomolybdic acid (PMA) 
stain. Flash chromatography was carried out on handpacked columns of silica gel 60 
(230 − 400 mesh). Melting points are uncorrected. Optical rotations were measured 
using a polarimeter with a thermally jacketted 5 cm cell at approximately 20 ºC and 
concentrations (c) are given in g/100 mL. Infrared analysis was performed with a 
spectrophotometer equipped with an ATR component; wavenumbers are given in cm-1. 
Mass spectra (EI) were obtained at 70 eV; and fragment ions in m/z with relative 
intensities (%) in parentheses. HRMS analyses were carried out using the Electron 
Impact (EI) mode at 70 eV or by Q-TOF using Electro Spray Ionization (ESI) mode. 
GC analyses were obtained with an HP-5 column (30 m × 0.25 mm, ID × 0.25 µm) and 
an EI (70 EV) detector. The temperature program: hold at 60 ºC for 3 min, ramp from 
60 ºC to 270 ºC at 15 ºC/min, hold at 270 ºC for 10 min. 1H NMR spectra were recorded 
at 300 or 400 MHz for 1H NMR and 75 or 100 MHz for 13C NMR, using CDCl3 or 
DMSO-d6 as the solvent and TMS as an internal Standard (0.00 ppm). The data is being 
reported as (s = singlet, d = doublet, t = triplet, m = multiplet or unresolved, br s = broad 
signal, coupling constant(s) in Hz, integration). 13C NMR spectra were recorded with 
1H-decoupling at 100 MHz and referenced to CDCl3 at 77.16 ppm or to DMSO-d6 at 
39.52 ppm. DEPT-135 experiments were performed to assign CH, CH2 and CH3. 
 
9-Allylphenanthrene (2). To a solution of 9-bromophenanthrene (918 mg, 3.5 mmol) 
in dry toluene (50 mL), under argon atmosphere, was added allyltributylstannane (2.17 
mL, 7 mmol), palladium tetrakis (464 mg, 0.35 mmol) and lithium chloride (178 mg, 
4.2 mmol). The resulting mixture was heated to 110 ºC for 2 h, when full conversion 
was verified by TLC. After cooling to room temperature, the mixture was diluted with 
EtOAc (50 mL), washed with brine (20 mL), dried over MgSO4 and concentrated to 
dryness. The obtained residue was purified by flash chromatography (hexane) to obtain 
the desired product as a white amorphous solid (693 mg, 91%): Rf 0.37 (100% Hexane); 
GC tR = 15.82 min. 1H NMR, 13C NMR, IR and MS were in agreement with previously 
reported data.21  
3-(Phenanthren-9-yl)propane-1,2-diol (3).  To a solution of compound 2 (540 mg, 
2.48 mmol) in acetone/water (35 mL/ 3.5 mL) were sequentially added 2,6-lutidine 
(0.90 mL, 7.80 mmol), NMO (704 mg, 5.8 mmol) and a solution of OsO4 in t-BuOH 
(2.5 % wt in t-BuOH, 0.90 mL). The mixture was stirred under argon atmosphere for 
3.5 h before being quenched with water (10 mL) and observing full consumption of the 
starting material by TLC. The mixture was extracted with EtOAc (3 x 15 mL) and the 
collected organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure. The solid obtained was recrystallized from EtOAc 
(~14 mL) to provide the pure diol 3 as a grey solid (300 mg). The filtrate was 
concentrated under reduced pressure to dryness and purified by column chromatography 
(1:1 hexane/EtOAc to 100% EtOAc) to afford another 133 mg of product (70% total 
yield): Rf  0.12 ( 1:1 hexane/EtOAc); IR ν 3377, 3290, 2884, 1385, 1305, 1112, 1033, 
842, 722  cm-1; 1H NMR (400 MHz, DMSO) δ 8.90 – 8.83 (m, 1H), 8.81 – 8.75 (m, 
1H), 8.24 – 8.17 (m, 1H), 7.94 – 7.88 (m, 1H), 7.74 – 7.58 (m, 5H), 4.76 – 4.69 (m, 
2H), 3.92 – 3.82 (m, 1H), 3.53 – 3.37 (m, 3H), 2.95 (dd, J  = 14.0, 7.9 Hz, 1H); 13C 
NMR (101 MHz, DMSO) δ 133.9  (C), 131.3 (C), 131.1 (C), 130.1 (C), 129.1 (C), 
127.9 (CH), 127.6 (CH), 126.8 (CH), 126.6 (CH), 126.3 (CH), 126.1 (CH), 124.7 (CH), 
123.3 (CH), 122.6 (CH), 71.5 (CH), 65.8 (CH2), 37.6 (CH2) ppm; LRMS (EI) m/z (%) 
252(M+, 36), 207 (19), 191 (100), 178 (14), 165 (12), 151 (4); HRMS (EI) calcd for 
C17H16O2  252.1150, found 252.1156. 
2-(Phenanthren-9-yl)acetaldehyde (4). To a suspension of diol 3 (350 mg, 1.39 mmol) 
in THF/H2O (14.25 mL/6.75 mL) was added NaIO4 (356 mg, 1.68 mmol) and the 
reaction mixture was stirred under argon atmosphere at 23 ºC for 2.5 h (full 
consumption of starting material by TLC). The THF was removed under reduced 
pressure and the aqueous phase was extracted with EtOAc (3 x15 mL). The collected 
organic layers were washed with brine, dried over MgSO4 and concentrated to dryness 
to furnish pure aldehyde 4 as a brownish solid in almost excellent yield (290 mg, 95%): 
Rf 0.38 (9:1 Hexane/EtOAc); GC tR = 16.66 min; IR ν 3075, 2922, 2851, 2820, 1710, 
739, 719 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.84 (t, J  = 2.4 Hz, 1H), 8.79 – 8.74 (m, 
1H), 8.69 (dd, J  = 8.2, 0.5 Hz, 1H), 7.92 (dd, J = 8.1, 1.3 Hz, 1H), 7.87 (dd, J  = 7.8, 
1.5 Hz, 1H), 7.74 – 7.59 (m, 5H), 4.14 (dd, J = 2.4, 0.6 Hz, 2H); 13C NMR (101 MHz, 
CDCl3) δ 200.0 (CHO), 131.6 (C), 131.2 (C), 130.9 (C), 130.4 (C), 129.5 (C), 128.5 
(C), 127.3 (CH), 127.1 (2CH + C), 126.9 (CH), 124.4 (CH), 123.5 (CH), 122.7(CH), 
48.9 (CH2); LRMS (EI) m/z (%) 220 (M+, 44), 191 (100), 165 (22), 94 (4), 82 (3); 
HRMS (EI) calcd for C16H12O  220.0888, found 220.0881. 
 (4R, SS)-(N-tert-Butylsulfinyl)-5-[9-phenantryl]-pent-1-en-4-amine (5). To a dry 
flask were added (SS)-N-tert-butylsulfinamide (161 mg, 1.33 mmol) followed by indium 
powder (191 mg, 1.66 mmol) under Ar. Then a solution of aldehyde 4 (306 mg, 1.39 
mmol) in dry THF (2.7 ml) and Ti(OEt)4 (0.6 mL, 2.66 mmol,) were added successively 
and the reaction mixture was stirred under argon for 1 h at 23 ºC. At this time allyl 
bromide (170 µL, 2.00 mmol) was added to the mixture and the reaction was allowed to 
reach 60 ºC and stirred at that temperature for 6 h. The mixture was allowed to reach 
room temperature and was carefully added over a stirring mixture of 4:1 EtOAc/brine 
(10 mL). The resulted white suspension was filtered through a short pad of Celite, 
washed with EtOAc and concentrated under reduced pressure. The resulted suspension 
was diluted in 4:1 EtOAc/hexane (50 mL) and filtered again through Celite. Organics 
were concentrated to dryness and the residue was purified by flash chromatography 
(hexane/EtOAc 7:3 to 6:4) to obtain the desired product as a white amorphous solid 
(328 mg, 68%, 95:5 according to 1H-NMR and HPLC, see ESI): [α]D20 4.8 (c 0.68, 
MeOH); Rf 0.16 (7:3 hexane/EtOAc); HPLC analysis [Tracer Excel 120 column 15 cm 
x 0.46 cm, isocratic elution with 99:1 n-hexane/i-PrOH, 1.0 mL/min, UV detection at 
254 nm, tR (minor diastereoisomer) 45.05 min/ tR (major diastereoisomer) 49.23 min]; 
IR ν 3216, 3075, 2958, 2925, 1636, 1449, 1260, 1048,747, 726 cm-1; 1H NMR (300 
MHz, CDCl3) δ 8.79 – 8.71 (m, 1H), 8.71 – 8.63 (m, 1H), 8.15 – 8.06 (m, 1H), 7.88 – 
7.79 (m, 1H), 7.74 – 7.54 (m, 5H), 5.96 – 5.77 (m, 1H), 5.23 (d, J  = 12,9, 2H), 3.90 – 
3.76 (m, 1H), 3.57 – 3.40 (m, 2H), 3.20 (dd, J  = 14.1, 7.3 Hz, 1H), 2.59 – 2.34 (m, 2H), 
1.10 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 134.3 (CH), 132.7131.6 (C), 131.2 (C), 
130.9 (C), 130.0 (C), 128.9 (CH), 128.2 (CH), 127.0 (CH), 126.9 (CH), 126.5 (CH), 
126.4 (CH), 124.5 (CH), 123.4 (CH), 122.6 (CH), 119.6 (CH), 55.9 (C), 54.7(CH), 40.3 
(CH2), 39.7 (CH2), 22.6 (CH3); LRMS (EI) m/z (%) 365 (M+, 0.2), 309 (55), 191 (100), 
165 (20), 118 (50), 70 (47), 57 (26), 41 (9); HRMS (ESI) calcd for C23H28NOS  
366.1892, found 366.1888. 
(4S, RS)-(N-tert-Butylsulfinyl)-5-[9-phenantryl]-pent-1-en-4-amine (ent-5). It was 
prepared from aldehyde 4 (330 mg, 1.50 mmol) and (RS)-N-tert-butylsulfinamide (173 
mg, 1.43 mmol) following the same procedure described above for compound 5. The 
expected compound was obtained as a white amorphous solid (365 mg, 70%) with 
identical spectroscopy and physical data than compound 5 except for [α]D20 −6.7 (c 
1.00, MeOH). 
(4R, SS)-(N-tert-Butylsulfinyl)-5-[9-phenantryl]-pent-1-ol-4-amine (6). To a solution 
of compound 5 (803 mg, 2.20 mmol) in dry THF (3.3 mL), at 0 ºC under argon 
atmosphere, was added a solution of 9-BBN in THF (13.2 mL, 0.5 M). The cooling bath 
was removed and the reaction mixture was stirred for 15 h at 25 ºC. The reaction 
mixture was cooled down to 0 ºC and a solution of 6M NaOH (5.9 mL) was carefully 
added, followed by H2O2 (5.1 mL, 33%). The reaction mixture was left stirring for 8 h, 
while the temperature increased to 25 ºC. The mixture was extracted with EtOAc (3 x 
20 mL), the collected organic layers were washed with water (10 x 5 mL), brine (1 x 5 
mL), dried over MgSO4 and concentrated to dryness. The crude product was purified by 
flash chromatography (EtOAc 100% to EtOAc/MeOH 98:2) to obtain the desired 
product as a white amorphous solid (725 mg, 86%): [α]D20 −11.4 (c 0.7, MeOH); Rf 
0.30 (98:2 EtOAc/MeOH); IR ν 3233, 3075, 2925, 2866, 1449, 1038, 747, 726 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 8.78 – 8.71 (m, 1H), 8.70 – 8.62 (m, 1H), 8.11 – 8.03 (m, 
1H), 7.86 – 7.78 (m, 1H), 7.71 – 7.54 (m, 5H), 3.84 – 3.56 (m, 4H), 3.35 (dd, J  = 14.0, 
7.1 Hz, 1H), 3.26 (dd, J  = 14.1, 6.4 Hz, 1H), 2.02 – 1.86 (m, 1H), 1.86 – 1.63 (m, 4H), 
1.04 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 132.9 (C), 131.6(C), 131.3(C), 130.9 (C), 
129.9 (C), 128.8 (CH), 128.2 (CH), 126.9 (CH), 126.8 (CH), 126.5 (CH), 126.4 (CH), 
124.4 (CH), 123.5 (CH), 122.6 (CH), 62.8 (CH2), 57.5 (CH),  56.0 (C), 41.1 (CH2), 
32.8 (CH2), 28.7 (CH2), 22.7 (CH3); LRMS (EI) m/z (%) 327 (M+-C4H8, 44), 245 (11), 
191 (100), 165 (22), 118 (70), 88 (60), 71 (51), 57 (27), 41 (9); HRMS (ESI) calcd for 
C23H30NO2S 384.1997, found 384.1980.  
(4S,RS)-(N-tert-Butylsulfinyl)-5-[9-phenantryl]-pent-1-ol-4-amine (ent-6). It was 
prepared following the same procedure described above for compound 6, showing 
identical spectroscopy and physical data except for [α]D20 +9.4 (c 0.9, MeOH). 
(2R,SS)- (N-tert-Butylsulfinyl)-2-(phenanthren-9-ylmethyl)pyrrolidine (7). To a 
solution of compound 6 (617 mg, 1.61 mmol) in dry THF (16 mL) under argon 
atmosphere was added PPh3 (512 mg, 1.95 mmol), followed by DIAD (400 μL, 2.03 
mmol) at 25 ºC. The reaction mixture turned yellow and was stirred for 16 h. The 
mixture was concentrated to dryness under reduced pressure and the residue was 
purified by flash chromatography (7:3 hexane/EtOAc). The desired product was 
obtained as a white amorphous solid (518 mg, 88%): [α]D20 +29.6 (c 0.95, MeOH); Rf 
0.24 (7:3 hexane/EtOAc); IR ν 3733, 3632, 2963, 1450, 1360, 1065, 748 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 8.77 – 8.71 (m, 1H), 8.70 – 8.63 (m, 1H), 8.19 – 8.11 (m, 1H), 
7.86 – 7.79 (m, 1H), 7.73 – 7.65 (m, 2H), 7.63 – 7.55 (m, 3H), 4.18 – 4.06 (m, 1H), 3.87 
– 3.76 (m, 1H) 3.68 (dd, J  = 13.5, 4.5 Hz, 1H), 2.97 – 2.84 (m, 2H), 1.98 – 1.83 (m, 
1H), 1.78 – 1.57 (m, 3H), 1.26 (s, J  = 4.2 Hz, 9H); 13C NMR (75 MHz, CDCl3) δ 133.3 
(C), 131.8 (C), 131.1 (C), 130.8 (C), 130.0 (C), 128.2 (CH), 127.8 (CH), 127.0 (CH), 
126.8 (CH), 126.5 (CH), 126.4 (CH), 124.7 (CH), 123.4 (CH), 122.6 (CH), 65.5 (CH), 
57.4 (C), 41.8 (CH2), 41.5 (CH2), 31.8 (CH2), 26.0 (CH2), 24.1 (CH3); LRMS (EI) m/z 
(%) 365 (M+, 0.1), 309 (M+-C4H8, 25), 191 (46), 118 (100), 70 (14), 57 (6), 41 (4); 
HRMS (EI) calcd for C19H19NOS  309.1187, found 309.1177.  
(2S,RS)- (N-tert-Butylsulfinyl)-2-(phenanthren-9-ylmethyl)pyrrolidine (ent-7). It 
was prepared following the same procedure described above for compound 7, showing 
identical spectroscopy and physical data except for [α]D20 −27.7 (c 0.95, MeOH). 
(R)-9,11,12,13,13a,14-Hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline (8). To a 
solution of compound 7 (244 mg, 0.67 mmol) in TFA (6 mL) under argon atmosphere, 
was added 37% aqueous CH2O (2.50 mL, 1.18 mL) and the reaction mixture was 
heated to 90 ºC for 12 h. After cooling to room temperature, H2O (15 mL) and 2 M 
NaOH (15 mL) were sequentially added to the mixture (pH > 12) and the product was 
extracted with EtOAc (3 x 40 mL). The collected organic layers were washed with 
brine, dried over MgSO4 and concentrated under reduced pressure. The orange solid 
obtained was purified by flash chromatography (CH2Cl2/MeOH 98:2 to 90:10) to 
obtain a pale yellow solid (164 mg, 90%, 95:5 er according to chiral HPLC): [α]D20 
−146 (c 1.0, CHCl3); mp 159-160 ºC (MeOH) {lit.19 mp 153-154 ºC for racemic 
mixture}; Rf 0.20 (95:5 CH2Cl2/MeOH); HPLC analysis [AD-H column 25 cm x 0.46 
cm, isocratic elution with 75:25:0.1 n-hexane/i-PrOH/Et3N, 1.0 mL/min, UV detection 
at 254 nm], tR (minor) 9.54 min, tR (major) 19.77 min. 1H NMR, 13C NMR, IR and MS 
were in agreement with previously reported data.19 
(S)-9,11,12,13,13a,14-Hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline (ent-8). 
It was prepared following the same procedure described above for compound 8, 
showing identical spectroscopy and physical data except for [α]D20 +138 (c 0.5, CHCl3). 
The analysis by chiral HPLC also showed a 95:5 er (See ESI for HPLC traces). 
2,3,6,7-Tetramethoxy-9-(2-methoxyvinyl)phenanthrene (10). To a suspension of t-
BuOK (469 mg, 4.2 mmol) in dry THF (25 mL) was added phosphonium salt (1.420 g, 
4.1 mmol) at 0 ºC and stirred during 30 min under argon atmosphere. Then the 
suspension was stirred for 20 min at room temperature, cooled again to 0 ºC and a 
solution of compound 9 (529 mg, 1.62 mmol) in CH2Cl2 (20 mL) was added. The 
reaction mixture was left stirring for 3 h while the temperature increased to 25 ºC. At 
this point, the reaction was quenched by adding a saturated solution of NH4Cl (25 mL). 
The mixture was extracted with EtOAc (3 x 25 mL) and the collected organic layers 
were washed with brine, dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude was purified by recrystallization from 1-propanol to give compound 
10 (481 mg, 84%) as a yellow solid (diastereomeric mixture, E/Z ratio ≈ 1.5/1): Rf 0.35 
(6:4 hexane/EtOAc); IR ν 2999, 2951, 2926, 2852, 1706, 1509, 1252, 1148, 773 cm-1; 
1H NMR (400 MHz, CDCl3) δ 8.03 (s, 0.43H, (Z)), 7.82 (s, 1H, (E)), 7.76 (s, 1H, (Z)), 
7.48 (d, J  = 12.9 Hz, 1H, (Z)), 7.43 (s, 0.56 H, (E)), 7.19 (d, J  = 10.7 Hz, 1H, (E/Z)), 
6.97 (d, J  = 12.4 Hz, 0.57H, (E)), 6.41 (d, J  = 7.1 Hz, 0.47H, (Z)), 6.38 (d, J  = 7.9 Hz, 
0.54H, (E)), 5.78 (d, J  = 7.1 Hz, 0.42H, (Z)), 4.12 (2 x s, 3H), 4.11 (2 x s, 3H), 4.05 (2 
x s, 3H), 4.03 (bs, 3H), 3.82 (2 x s, 3H); 13C NMR (101 MHz, CDCl3) δ 150.0 (CH), 
149.14 (C), 149.10 (C), 149.05 (C), 149.01 (C), 148.9 (C), 148.84 (C), 148.7 (C), 148.6 
(CH), 148.6 (C), 129.7 (C), 127.5 (C), 126.7 (C), 126.6 (C), 125.6 (C), 125.2 (CH), 
125.1 (C), 124.8 (C), 123.9 (C), 123.7 (C), 121.8 (CH), 108.5 (CH), 108.2 (CH), 105.4 
(CH), 105.3 (CH), 103.4 (CH), 103.3 (CH), 103.0 (CH), 102.9 (CH), 102.4 (CH), 60.8 
(CH), 57.3 (CH), 56.3 (CH3), 56.2 (CH3), 56.17 (CH3), 56.0 (CH3), 55.96 (CH3); 
LRMS (EI) m/z (%) 354 (M+, 100), 339 (15), 324 (10), 308 (17), 177 (7); HRMS (EI) 
calcd for C21H22O5  354.1467, found 354.1466.  
2-(2,3,6,7-Tetramethoxyphenanthren-9-yl)acetaldehyde (11). To a suspension of 
compound 10 (531 mg, 1.5 mmol) in dry THF (1.85 mL) was added a solution of 3M 
HCl (0.65 mL).The mixture was stirred and heated to 75 ºC  under argon atmosphere for  
2.5 h, before being quenched with aqueous solution of NaHCO3 (6 mL, 10%). The 
mixture was extracted with CH2Cl2 (3 x 10 mL), and the collected organic layers were 
washed with brine (5 mL), dried over MgSO4 and concentrated in vacuo. The residue 
was purified by flash chromatography (hexane/EtOAc 65:35 to 55:45) to obtain a 
yellow amorphous solid (454 mg, 89%): Rf 0.32 (1:1 hexane/EtOAc); 1H NMR, 13C 
NMR and MS were in agreement with previously reported data.13  
(4R, SS)-(N-tert-Butylsulfinyl)-5-[2,3,6,7-tetramethoxyphenanthren-9-yl]-pent-1-
en-4-amine (12). To a mixture of aldehyde 11 (622 mg, 1.83 mmol), (SS)-N-tert-
butylsulfinamide (210 mg, 1.74 mmol), indium powder (252 mg, 2.20 mmol) in dry 
THF (3.5 mL), was added  Ti(OEt)4 (0.8 mL, 3.48 mmol,) at 25 ºC. After 3 h, allyl 
bromide (226 µL, 1.4 mmol) was added to the mixture and the reaction was allowed to 
reach 65 ºC and stirred at that temperature for 6 h. The mixture was allowed to reach 
room temperature and was carefully added over a stirring mixture of 4:1 EtOAc/brine 
(25 mL). The resulted white suspension was filtered through a short pad of Celite, 
washed with EtOAc (5 x 20 mL) and concentrated under reduced pressure. The crude 
was purified by flash chromatography (hexane/EtOAc 3:7) to obtain the desired product 
as a pale yellow solid (672 mg, 75%, 95:5 according to 1H-NMR and HPLC): [α]D20 
+34.8 (c 1.2, CHCl3);{lit13 [α]D25 +42.6 (c 1.0,  CHCl3)}; Rf 0.22 (3:7 hexane/EtOAc); 
HPLC analysis [Tracer Excel 120 column 15 cm x 0.46 cm , isocratic elution with 95:5 
n-hexane/i-PrOH, 1.0 mL/min, UV detection at 254 nm], tR (minor) 14.71 min / tR 
(major) 17.16 min]; 1H NMR, 13C NMR, IR and MS were in agreement with previously 
reported data. 13 
 (4R,SS)-(N-tert-Butylsulfinyl)-5-[2,3,6,7-tetramethoxyphenanthren-9-yl]-pent-1-ol-
4-amine (13). To a solution of compound 12 (485 mg, 1 mmol) in dry THF (1 mL) was 
added a solution of 9-BBN in THF (6 mL, 0.5M) at 0 ºC, under argon. After being 
stirred for 15 h at room temperature, a solution of 6M NaOH (2.7 mL)  followed by 
H2O2 (3.3 mL, 33%) were added to the mixture with ice cooling. The reaction mixture 
was left stirring for 8 h, while the temperature increased to 25 ºC. The mixture was 
extracted with EtOAc (3 x 20  mL), the collected organic layers were washed with water 
(10 x 5 mL), brine (1 x 5 mL), dried over MgSO4 and concentrated to dryness. The 
crude product was purified by flash chromatography (EtOAc/MeOH 98:2 to 95:5) to 
obtain the desired product as a white amorphous solid (403 mg, 80%): [α]D20 -5.7 (c 
1.03, MeOH); Rf 0.15  (98:2 EtOAc/MeOH); IR ν 3298, 3179, 3003, 2930, 2830, 1614, 
1509, 1470, 1252, 1146, 1029, 836, 774 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.82 (s, 
1H), 7.76 (s, 1H), 7.40 (d, J  = 11.3 Hz, 2H), 7.15 (s, 1H), 4.12 (s, 3H), 4.11 (s, 3H), 
4.08 (s, 3H), 4.02 (s, 3H), 3.84 (d, J  = 5.5 Hz, 1H), 3.81 – 3.71 (m, 1H), 3.71 – 3.63 (m, 
1H), 3.63 – 3.53 (m, 1H), 3.36 (dd, J  = 14.0, 6.2 Hz, 1H), 3.09 (dd, J  = 14.0, 7.5 Hz, 
1H), 2.51 (s, 1H), 1.98 – 1.81 (m, 1H), 1.81 – 1.64 (m, 3H), 1.10 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 149.1 (C), 149.0 (2C), 148.9 (C), 130.2 (C), 126.3 (CH), 126.2 (C), 
125.4 (C), 125.1 (C), 123.9 (C), 108.0 (CH), 104.8 (CH), 103.6 (CH), 102.9 (CH), 
62.69 (CH2), 56.8 (CH), 56.3 (CH3), 56.2 (CH3), 56.1 (CH3), 56.0 (CH3), 55.9 (C), 
41.5 (CH2), 32.3 (CH2), 28.7 (CH2), 22.7 (CH3); LRMS (EI) m/z (%) 503 (M+, 8.3), 
447 (5), 382 (7), 311 (100), 118 (25), 88 (26), 71(13), 57 (13), 46 (9); HRMS (ESI) 
calcd for C27H38NO6S [M + H]+ 504.2420, found 504.2411. 
(R)-Tylophorine. To a solution of compound 13 (312 mg, 0.62 mmol) in dry THF (6.2 
mL) under argon atmosphere was added PPh3 (195 mg, 0.74 mmol), followed by DIAD 
(154 μL, 0.78 mmol) at 25 ºC. The reaction mixture turned yellow and was stirred for 
16 h. The mixture was concentrated to dryness under reduced pressure and the residue 
was purified by flash chromatography (hexane/EtOAc 4:6 to 75% EtOAc). The 
obtained intermediate 14 [Rf 0.16 (3:7 hexane/EtOAc)] was contaminated with 
triphenylphosphine oxide according to 1H NMR, and used in the next step without 
further purification.  
To a mixture of compound 14 (155.2 mg, 0.52 mmol) in MeOH (5.2 mL) was added a 
solution of 4 M HCl in dioxane (3.25 mL) at 0 ºC, under argon atmosphere. The mixture 
was stirred 1 h at 25 ºC, then was added 37% formaldehyde (10.4 mL) and the solution 
was heated to 90 ºC and stirred for 12 h in the dark. The cooled mixture was diluted 
with water (20 mL) and solution of 2 M NaOH (20 mL). The organics phases were 
extracted with CH2Cl2 (3 x 25 mL) and washed with water (10 mL) and brine (10 mL), 
dried over Na2SO4, and concentrated. The crude product was purified by flash column 
(100% CH2Cl2 to 95:5 CH2Cl2/MeOH), to obtain the desired product as a yellow solid 
(171 mg, 70%): [α]D20 -85.0 (c 0.5, CHCl3). {lit13 [α]D20 -87 (c 1.0,  CHCl3)}; Rf 0.38 
(95:5 CH2Cl2/MeOH); 1H NMR, 13C NMR, IR and MS were in agreement with 
previously reported data. 9b, 10b, 11 
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